Hepatitis A News and Research

RSS

Hepatitis A (formerly known as ''infectious hepatitis'') is an acute infectious disease of the liver caused by the hepatitis A virus (HAV), which is most commonly transmitted by the fecal-oral route via contaminated food or drinking water.

Blood pressure drug reverses liver damage

British scientists have discovered that blood-pressure drugs can reverse the effects of early-stage liver failure in some patients.

1 Jun 2009

MicroRNAs grease the cell's circadian clockwork

Most of our cells possess an internal clock, a group of genes displaying a cyclic expression pattern that reaches a peak once a day. A large number of circadian genes are expressed by organs such as the liver, whose activity needs to be precisely regulated over the course of the day.

31 May 2009

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.

31 May 2009

Thai HIV/AIDS advocates urge increased treatment access for IDUs

The Thai AIDS Treatment Action Group recently called on the country to launch a comprehensive harm reduction program for injection drug users in an effort to help curb the spread of HIV, Thailand's The Nation reports.

31 May 2009

'Complacency,' 'stigma' hindering efforts to reduce HIV/AIDS in black communities, opinion piece says

"Nearly 30 years after the discovery of HIV and AIDS, the epidemic is still ravaging black neighborhoods in Baltimore and across the nation," Kevin Fenton -- director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention -- writes in a Baltimore Sun opinion piece.

28 May 2009

Hospital refuses admission to young adults with thalassemia and sickle cell disease

Young adults with thalassemia and sickle cell diease have been trying for up to 10 years to gain admission to the only adult hospital program in central and southwestern Toronto specialized to treat their blood disorders. Since 1999, the Toronto General Hospital (TGH) has restricted the inherited blood disorders program to 99 patients requiring blood transfusions. As a result, about 150 young adults with complex disorders receive blood transfusions at the Hospital for Sick Children but no adult services.

25 May 2009

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).

20 May 2009

'Swift action driven by courage needed' to remove ban on federal funding for needle-exchange programs, letter to editor says

"The Obama administration's budget dealt a serious blow to those who support syringe exchange programs to prevent the transmission of HIV, hepatitis C and other infectious diseases," Paola Barahona, senior global health policy analyst for Physicians for Human Rights and founding executive director of Prevention Works!, writes in a Washington Post letter to the editor.

19 May 2009

Denver Post examines efforts to establish needle-exchange programs in Colorado

The Denver Post on Friday examined efforts to establish needle-exchange programs in Colorado to reduce the risk of HIV and hepatitis C among injection drug users.

18 May 2009

Chronic infection clearly linked to key immunity protein

The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body's defense system.

15 May 2009

Swine flu preoccupies world health leaders

It is expected that the upcoming World Health Organisation's (WHO) annual assembly will be dominated this year by the emergence and spread of the new influenza virus H1N1 (swine flu).

14 May 2009

About 20% of surveyed sex workers who use drugs in Irish capital living with HIV, report finds

About one-fifth of commercial sex workers surveyed in Dublin, Ireland, are HIV-positive, while 78% of the surveyed group is living with hepatitis C, according to a report released Tuesday by the National Advisory Committee on Drugs, the Irish Times reports.

14 May 2009

Cimzia approved in U.S. for rheumatoid arthritis

UCB announced today that the U.S. Food and Drug Administration (FDA) approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

13 May 2009

New insights into immune exhaustion

A main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out.

13 May 2009

HIV cases among young people in Iowa increasing

Health officials announced recently that the number of newly recorded HIV cases among Iowans ages 15 to 24 increased by 45% in 2008 to 16, despite the widespread availability of condoms and other prevention methods, the Iowa Press-Citizen reports.

12 May 2009

Pioneering technique for treatment of liver tumours

Leicester consultant surgeon who has developed a pioneering technique using microwaves to destroy liver tumours has treated more than 100 patients in the UK and other patients are now being treated internationally.

12 May 2009

New understanding on mechanisms of early stage liver reperfusion injury

Reperfusion of a previously ischemic tissue is associated with additional injury leading to structural and functional alterations in many organs including the liver.

7 May 2009

Scientists create human monoclonal antibody that neutralizes the Hepatitis C virus

Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).

5 May 2009

Women with a history of hypothyroidism at greater risk of developing liver cancer

Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.

4 May 2009

Canadian Court to determine constitutionality of law preventing supervised drug-injection sites

The British Columbia Court of Appeals this week is hearing a case to decide whether certain sections of Canada's Controlled Drugs and Substances Act that prevent injection drug users from accessing services at the supervised drug-injection facility Insite in Vancouver, British Columbia, are constitutional, Toronto's Globe and Mail reports (Stueck, Globe and Mail, 4/28).

30 Apr 2009

Hepatitis A News and Research

Further Reading

Blood pressure drug reverses liver damage

MicroRNAs grease the cell's circadian clockwork

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Thai HIV/AIDS advocates urge increased treatment access for IDUs

'Complacency,' 'stigma' hindering efforts to reduce HIV/AIDS in black communities, opinion piece says

Hospital refuses admission to young adults with thalassemia and sickle cell disease

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

'Swift action driven by courage needed' to remove ban on federal funding for needle-exchange programs, letter to editor says

Denver Post examines efforts to establish needle-exchange programs in Colorado

Chronic infection clearly linked to key immunity protein

Swine flu preoccupies world health leaders

About 20% of surveyed sex workers who use drugs in Irish capital living with HIV, report finds

Cimzia approved in U.S. for rheumatoid arthritis

New insights into immune exhaustion

HIV cases among young people in Iowa increasing

Pioneering technique for treatment of liver tumours

New understanding on mechanisms of early stage liver reperfusion injury

Scientists create human monoclonal antibody that neutralizes the Hepatitis C virus

Women with a history of hypothyroidism at greater risk of developing liver cancer

Canadian Court to determine constitutionality of law preventing supervised drug-injection sites

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News